Nordics Seasonal Influenza Vaccine Market Forecast in (Denmark, Finland, Iceland, Norway & Sweden) By (Child & Adult) Vaccination

Publisher Name :
Date: 21-Mar-2017
No. of pages: 90
Inquire Before Buying

Nordics Seasonal Influenza Vaccine Market Forecast in (Denmark, Finland, Iceland, Norway & Sweden) By (Child & Adult) Vaccination report published by Renub Research. According to this report, Sweden is having the highest seasonal influenza vaccine market share. In terms of children vaccination, Sweden & Denmark hold nearly 70 percent market share in 2016 whereas, in adult vaccination segments, these two will share more than 60 percent market share by 2022.

This report provides a complete analysis of 5 Nordic countries (Denmark, Finland, Iceland, Norway and Sweden) Seasonal Influenza Vaccine Market for Childhood & Adolescent, Number of Vaccinated Population for Childhood & Adolescent and Forecast till 2022. All the 5 countries in the report have been studied from 2 viewpoints.

Seasonal Influenza Vaccine Market in Nordic Countries (2011 – 2022)


  • Seasonal Influenza Vaccine Market & Forecast

  • Children Seasonal Influenza Vaccine Market & Forecast

  • Adult Seasonal Influenza Vaccine Market & Forecast


Seasonal Influenza Vaccinated Population in Nordic Countries (2011 – 2022)


  • Seasonal Influenza Vaccinated Population & Forecast

  • Children Seasonal Influenza Vaccinated Population & Forecast

  • Adult Seasonal Influenza Vaccinated Population & Forecast


Countries studied in the report are as follows


  • Denmark

  • Finland

  • Iceland

  • Norway

  • Sweden

Nordics Seasonal Influenza Vaccine Market Forecast in (Denmark, Finland, Iceland, Norway & Sweden) By (Child & Adult) Vaccination

Table of contents

1. Executive Summary

2. Nordic Countries Seasonal Influenza Vaccinated Population
2.1 Seasonal Influenza Vaccinated Child Population in Nordic Countries
2.2 Seasonal Influenza Vaccinated Adult Population in Nordic Countries

3. Nordic Countries Seasonal Influenza Vaccine Market
3.1 Seasonal Influenza Child Vaccine Market in Nordic Countries
3.2 Seasonal Influenza Adult Vaccine Market in Nordic Countries

4. Nordic Countries Seasonal Influenza Vaccine Market Share Analysis
4.1 Nordic Countries Seasonal Influenza Vaccine Market Share
4.2 Nordic Countries Seasonal Influenza Child Vaccine Market Share
4.3 Nordic Countries Seasonal Influenza Adult Vaccine Market Share

5. Denmark
5.1 Denmark Seasonal Influenza Vaccinated Total Population
5.1.1 Denmark Seasonal Influenza Vaccinated Child Population
5.1.2 Denmark Seasonal Influenza Vaccinated Adult Population
5.2 Denmark Seasonal Influenza Vaccine Market
5.2.1 Denmark Seasonal Influenza Child Vaccine Market
5.2.2 Denmark Seasonal Influenza Adult Vaccine Market

6. Finland
6.1 Finland Seasonal Influenza Vaccinated Total Population
6.1.1 Finland Seasonal Influenza Vaccinated Child Population
6.1.2 Finland Seasonal Influenza Vaccinated Adult Population
6.2 Finland Seasonal Influenza Vaccine Market
6.2.1 Finland Seasonal Influenza Child Vaccine Market
6.2.2 Finland Seasonal Influenza Adult Vaccine Market

7. Iceland
7.1 Iceland Seasonal Influenza Vaccinated Total Population
7.1.1 Iceland Seasonal Influenza Vaccinated Child Population
7.1.2 Iceland Seasonal Influenza Vaccinated Adult Population
7.2 Iceland Seasonal Influenza Vaccine Market
7.2.1 Iceland Seasonal Influenza Child Vaccine Market
7.2.2 Iceland Seasonal Influenza Adult Vaccine Market

8. Norway
8.1 Norway Seasonal Influenza Vaccinated Total Population
8.1.1 Norway Seasonal Influenza Vaccinated Child Population
8.1.2 Norway Seasonal Influenza Vaccinated Adult Population

8.2 Norway Seasonal Influenza Vaccine Market
8.2.1 Norway Seasonal Influenza Child Vaccine Market
8.2.2 Norway Seasonal Influenza Adult Vaccine Market

9. Sweden
9.1 Sweden Seasonal Influenza Vaccinated Total Population
9.1.1 Sweden Seasonal Influenza Vaccinated Child Population
9.1.2 Sweden Seasonal Influenza Vaccinated Adult Population
9.2 Sweden Seasonal Influenza Vaccine Market
9.2.1 Sweden Seasonal Influenza Child Vaccine Market
9.2.2 Sweden Seasonal Influenza Adult Vaccine Market

10. Seasonal Influenza Vaccine - Growth Drivers
10.1 Vaccine Manufacturers Plan to Increase Flu Vaccine Production
10.2 Growing Child & Ageing Population in Nordic Region
10.3 Rising Healthcare Expenditure Share of the Nordic Countries GDP

11. Seasonal Influenza Vaccine – Challenges
11.1 Regulatory Challenges with New and Novel Influenza Vaccines
11.2 Lack of Healthcare Infrastructure
11.3 Limited Reimbursement and Access to the Vaccines

List of Tables

Table 10 1: Nordic Countries - Healthcare Expenditure Share (Percent) of GDP, 2005 – 2015

List of Figures

Figure 2 1: Nordic Countries - Seasonal Influenza Vaccinated Population (Thousand), 2011 - 2016
Figure 2 2: Nordic Countries – Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 - 2022
Figure 2 3: Nordic Countries - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 2 4: Nordic Countries – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 2 5: Nordic Countries - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 2 6: Nordic Countries – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 3 1: Nordic Countries - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 3 2: Nordic Countries – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 3 3: Nordic Countries - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 3 4: Nordic Countries – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 3 5: Nordic Countries - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 3 6: Nordic Countries – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 4 1: Nordic Countries - Seasonal Influenza Vaccine Market Share (Percent), 2011 - 2016
Figure 4 2: Nordic Countries – Forecast for Seasonal Influenza Vaccine Market Share (Percent), 2017 - 2022
Figure 4 3: Nordic Countries - Seasonal Influenza Child Vaccine Market Share (Percent), 2011 - 2016
Figure 4 4: Nordic Countries – Forecast for Seasonal Influenza Child Vaccine Market Share (Percent), 2017 - 2022
Figure 4 5: Nordic Countries - Seasonal Influenza Adult Vaccine Market Share (Percent), 2011 - 2016
Figure 4 6: Nordic Countries – Forecast for Seasonal Influenza Adult Vaccine Market Share (Percent), 2017 - 2022
Figure 5 1: Denmark - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 5 2: Denmark – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 5 3: Denmark - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 5 4: Denmark – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 5 5: Denmark - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 5 6: Denmark – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 5 7: Denmark - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 5 8: Denmark – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 5 9: Denmark - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 5 10: Denmark – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 5 11: Denmark - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 5 12: Denmark – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 6 1: Finland - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 6 2: Finland – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 6 3: Finland - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 6 4: Finland – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 6 5: Finland - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 6 6: Finland – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 6 7: Finland - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 6 8: Finland – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 6 9: Finland - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 6 10: Finland – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 6 11: Finland - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 6 12: Finland – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 7 1: Iceland - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 7 2: Iceland – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 7 3: Iceland - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 7 4: Iceland – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 7 5: Iceland - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 7 6: Iceland – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 – 2022
Figure 7 7: Iceland - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 7 8: Iceland – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 7 9: Iceland - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 7 10: Iceland – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 7 11: Iceland - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 7 12: Iceland – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 8 1: Norway - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 8 2: Norway – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 8 3: Norway - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 – 2016
Figure 8 4: Norway – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 – 2022
Figure 8 5: Norway - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 8 6: Norway – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 8 7: Norway - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 8 8: Norway – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 8 9: Norway - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 8 10: Norway – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 8 11: Norway - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 8 12: Norway – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 9 1: Sweden - Seasonal Influenza Vaccinated Population (Thousand), 2011 - 2016
Figure 9 2: Sweden – Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 - 2022
Figure 9 3: Sweden - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 9 4: Sweden – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 9 5: Sweden - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 9 6: Sweden – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 9 7: Sweden - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 9 8: Sweden – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 9 9: Sweden - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 9 10: Sweden – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 9 11: Sweden - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 9 12: Sweden – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 10 1: Vaccine Manufacturers – Influenza Vaccine Production (Million Doses), 2013-2015
Figure 10 2: Nordic Countries – Child Population (Thousand), 2010 – 2016
Figure 10 3: Nordic Countries – Forecast for Child Population (Thousand), 2017 – 2022
Figure 10 4: Nordic Countries – Ageing Population (Thousand), 2010 – 2016
Figure 10 5: Nordic Countries – Forecast for Ageing Population (Thousand), 2017 – 2022

  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs